An asynchronous electronic consent for improving consent in research among patients with cancer.

ABSTRACT:

Background

Informed consent is essential to ensuring ethical conduct of clinical research in oncology, but can be challenging and time-consuming to implement. Electronic consenting (e-consent) may address these issues, but acceptability of e-consent among patients with cancer must be assessed.

Methods

An asynchronous preliminary e-consent was developed for a prospective circulating tumor DNA testing study for patients with colorectal/pancreatic cancer. Following e-consent, patient satisfaction was assessed in a follow-up call before full consent was obtained. Acceptability was assessed with descriptive statistics and bivariate analysis.

Results

Fifty-one participants completed the preliminary e-consent, 90% of which preferred electronic full consent over traditional c

SUBMITTER: Chia BJ 

PROVIDER: S-EPMC12557314 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature